Pricing Log in Create free account

Aclaris Therapeutics, Inc. (ACRS) vs Indaptus Therapeutics, Inc. (INDP)

Aclaris Therapeutics, Inc. and Indaptus Therapeutics, Inc. are both Biotechnology companies. Aclaris Therapeutics, Inc. is the larger, with a market value of $550.5M against $497.6M — 1.1× the size. Indaptus Therapeutics, Inc. has the higher net margin (0.00% vs −921.5%) and the higher return on invested capital (0.00% vs −163.4%). Across the 13 metrics below, Indaptus Therapeutics, Inc. leads on 7 and Aclaris Therapeutics, Inc. on 6.

Valuation

Metric ACRS INDP Biotechnology median
P/E n/m n/m 10.64
P/S 64.95 n/m 9.59
P/B 4.29 33.39 2.15
Price to free cash flow n/m n/m 26.07
EV/EBITDA n/m n/m 0.65
EV/Sales 55.12 n/m 9.45
Earnings yield (15.51%) (236.87%) (34.69%)
Free cash flow yield (11.65%) (3.87%) (24.02%)

Profitability

Metric ACRS INDP Biotechnology median
Gross margin 12.90% 0.00% 65.59%
Operating margin (1,050.16%) 0.00% 0.00%
Net margin (921.50%) 0.00% 0.00%
Free cash flow margin (756.50%) 0.00% 0.00%
Return on equity (59.10%) (318.04%) (51.96%)
Return on assets (41.07%) (163.84%) (46.06%)
Return on invested capital (163.35%) 0.00% 0.00%

Growth

Metric ACRS INDP Biotechnology median
Revenue growth (TTM) (51.04%) — 4.59%
EPS growth (last fiscal year) 69.01% 52.15% 29.88%
Revenue growth, 5-year CAGR 3.84% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACRS INDP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.46 19.48 4.86
Net debt to EBITDA 1.20 0.43 1.01

Dividend

Metric ACRS INDP Biotechnology median
Dividend yield — — 0.38%
Payout ratio — — —

Size

Metric ACRS INDP Biotechnology median
Market cap 550.53m 497.60m 174.29m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack